Curtin University: New Trial Examines Common Household Pill to Reduce Liver Cancer Risk
May 13, 2025
May 13, 2025
PERTH, Australia, May 13 -- Curtin University issued the following news release:
* * *
New trial examines common household pill to reduce liver cancer risk
A daily dose of aspirin will be prescribed to people living with chronic liver disease in a bid to lower their chances of developing a common and deadly form of liver cancer as part of a new Curtin-led clinical trial.
The five-year clinical trial, led by Professor John Olynyk from the Curtin . . .
* * *
New trial examines common household pill to reduce liver cancer risk
A daily dose of aspirin will be prescribed to people living with chronic liver disease in a bid to lower their chances of developing a common and deadly form of liver cancer as part of a new Curtin-led clinical trial.
The five-year clinical trial, led by Professor John Olynyk from the Curtin . . .